nanomedicine Archives | Be Korea-savvy

S. Korean Biotech Firms Increase Nanomedicine-Related Investment and Research Efforts

SEOUL, Aug. 30 (Korea Bizwire) — South Korea’s pharmaceutical and biomedical companies are doubling down on nanomedicine-related investment and research efforts. The Life Science Fund, created jointly by Samsung C&T Corp. and Samsung Biologics Co., decided to invest 19 billion won (US$14 million) in U.S.-based biotech firm Senda Biosciences Inc. last week. Senda possesses the [...]

Nanobiotix Announces Publication of Phase III Soft Tissue Sarcoma Data for First-in-class NBTXR3 in the Lancet Oncology

Paris, France and Cambridge, Massachusetts, USA, Jul. 9 (Korea Bizwire) – NANOBIOTIX (Euronext: NANO – ISIN: FR0011341205), a clinical-stage nanomedicine company pioneering new approaches to the treatment of cancer, today announced that the previously reported results from the Phase II/III Act.In.Sarc trial evaluating NBTXR3 in patients with advanced STS have been published online in The [...]